BPA Call 75H71221A00014-75H71223F28002
Award Date 11/29/22
Potential Completion Date 11/28/23
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46250, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Roche Diabetes Care Inc. received a $201,132 firm fixed-price Blanket Purchase Agreement (BPA) call award from the Indian Health Service (IHS) on September 23, 2021, for the supply of diabetic testing supplies to the Phoenix Indian Medical Center (PIMC) in Phoenix, Arizona. This contract, which concluded on September 26, 2022, was awarded without a set-aside designation, indicating open competition. The award falls under the General Services Administration's In-vitro Diagnostics, Reagents, and...
- Roche Diabetes Care Inc. received a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $250,000 from the Indian Health Service (IHS) on August 7, 2025, with an ultimate completion date of September 26, 2026. This non-competitive award is performed at the Phoenix Indian Medical Center in Phoenix, Arizona, and falls under the GSA's In-vitro Diagnostics, Reagents, and Test schedule (FSS-65-VII). The contract supports IHS's mission to provide comprehensive diabetes management...
- This federal contract award is a Blanket Purchase Agreement (BPA) call placed against the Roche Diabetes Care, Inc. contract on the General Services Administration (GSA) Federal Supply Schedule for in vitro diagnostics, reagents, and test kits (Contract V797D-50597). The $156,480.00 order is for diabetic testing supplies, including test strips, meters, and related consumables, to support the operations of the Phoenix Indian Medical Center, which is part of the Indian Health Service (IHS) under...
- The Department of Health and Human Services Indian Health Service awarded a $250,000 delivery order contract to Roche Diabetes Care Inc. under the company's General Services Administration Federal Supply Schedule contract for invitro diagnostics, reagents, and test kits. The one-year firm fixed price contract, which runs from October 25, 2023 to October 24, 2024, is for the provision of diabetic testing supplies to be delivered to a location in Castleton, Indiana. Roche Diabetes Care Inc. will...
- The Department of Health and Human Services Indian Health Service awarded a $204,000 purchase order to Roche Diabetes Care Inc. for medical supplies under the GIMC BPA ROCHE DIABETES CARE blanket purchase agreement. Roche Diabetes Care, Inc. Division will provide diabetes care products and services to support the Indian Health Service's healthcare programs in Gallup, New Mexico. The firm fixed price contract runs from September 2022 through September 2025. No subcontractors or set aside...
- This is a firm-fixed-price purchase order contract awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Roche Diabetes Care Inc. The $87,320.04 contract is for the delivery of diabetic supplies, including test strips, meters, lancets, and control solutions, to support the IHS's comprehensive diabetes programs. Roche has previously held Blanket Purchase Agreements (BPAs) with IHS, worth up to $1.66 million and $2 million, to...
- This is a firm-fixed-price delivery order awarded by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Roche Diabetes Care Inc. for the provision of diabetes supplies. The $1,280,826.00 order is placed against Roche's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and test kits. The contract does not have a set-aside designation. Roche, a leading manufacturer of...
- This Federal contract award, ID 75H71221A00014|75H71225F28005, was issued by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Roche Diabetes Care Inc. The contract is for the delivery of diabetic testing supplies, including blood glucose monitors, test strips, lancets, and control solutions, to support the IHS's diabetes management programs. The contract has a maximum ceiling value of $250,000.00 and was awarded on October 23, 2024 as a...
- This is a federal contract awarded by the Department of Health and Human Services (HHS) Indian Health Service (IHS) to Roche Diabetes Care Inc., a manufacturer and supplier of diabetes management products and services. The contract is for the delivery of diabetic testing device kits, lancets, and test strips, with a potential value of $667,707.00. The contract was awarded on December 13, 2019 and has a completion date of October 20, 2023. It is a Delivery Order contract awarded under Roche's...
- This contract award to Roche Diabetes Care Inc. for $99,966.00 was issued by the Indian Health Service (IHS), which is part of the U.S. Department of Health and Human Services. The award is a delivery order under Roche's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and test kits. This order is for outpatient diabetes supplies such as test strips, meters, and related consumables to support IHS diabetes programs. The contract...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- V797D50597-75H71221A00014Blanket Purchase Agreement
- 75H71221A00014-75H71223F28002BPA Call
The Department of Health and Human Services Indian Health Service awarded a $250,000 Blanket Purchase Agreement Call contract to Roche Diabetes Care Inc. for Diabetic Testing Supplies for the Phoenix Indian Medical Center. Roche Diabetes Care Inc. will provide these supplies under its Roche Diabetes Care, Inc. Division and through its Master GSA Schedule Contract for In Vitro Diagnostics, Reagents, and Test Kits. The contract has a base period of performance from November 29, 2022 through November 28, 2023 and utilizes a Firm Fixed Price pricing structure.
Generated 11/28/23, 4:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $250.0k | 11/29/22 |